What we are funding

Explore some of the hundreds of research grants that World Cancer Research Fund has awarded. You can filter your search by cancer type, location, institution or researcher.

If you need help finding a grant, get in touch with the Research team: research@wcrf.org

> View our map of research grants to see where we’re funding

  • By institution

  • By country

  • By cancer type / topic

  • Status

Your search produced the following results:

Physical activity, sedentary behaviour and cancer risk in people with comorbidities

Michael Leitzmann — University of Regensburg

It is thought that there are links between the presence of an existing illness, such as diabetes or cardiovascular disease, and the development of cancer.

This project will find out if physical activity and sedentary behaviours can affect the risk of developing cancer in people with comorbidities.

Status: Ongoing

Vitamin D and lifestyle, large bowel cancer development and Lynch syndrome

Franzel van Duijnhoven — Wageningen University and Research Centre

People with Lynch syndrome have an increased risk of developing large bowel cancer and it is thought that vitamin D may play a role.

This study will pool data from numerous studies to determine how lifestyle factors and vitamin D levels can affect the risk of large bowel cancer to develop tailored cancer prevention recommendations for this population.

Status: Ongoing

How short-term fasting can improve chemotherapy in breast cancer patients

Judith Kroep — Leiden University Medical Center

Short-term fasting-mimicking diets (FMD) have been shown to enhance the effects of chemotherapy while reducing the adverse effects for breast cancer tumours, but the mechanisms of this are not yet known.

This project will aim to understand the impact of FMD on the immune cells of the tumour and evaluate the impact of the FMD on survival, quality of life and cognition.

Status: Ongoing

Do sugary drinks increase pancreatic cancer risk?

Alessandro Carrer — Veneto Institute of Molecular Medicine

Pancreatic cancer is among the deadliest forms of cancer, and there is evidence of a link between high fructose consumption and the risk of developing this cancer. This study will use mouse models to identify the processes linking fructose consumption and pancreatic cancer.

Status: Ongoing

How does consuming cow milk affect colon cancer risk?

Timo Bund — German Cancer Research Center (DKFZ)

Long-term consumption of viruses or infectious molecules in bovine products may result in chronic inflammation in the colon, damaging the cells that may develop into tumour precursors.

This study will investigate how the viruses and molecules enter and persist in cells, which changes are induced and how this can be prevented to reduce cancer risk.

Status: Ongoing

Sleep quality, fatigue and inflammation after colorectal cancer treatment

Matty Weijenberg — Maastricht University

Sleep deficiency and fatigue affect up to two-thirds of colorectal cancer survivors and can persist for years. This pilot study will help quantify and understand how daily eating and physical behaviour patterns are associated with sleep quality, fatigue and inflammation over time.

This will help to develop intervention studies and eventually to empower fatigued colorectal cancer survivors.

Status: Ongoing

Helping colorectal cancer survivors at risk of cardiovascular disease

Mitch Duncan — University of Newcastle

Colorectal cancer (CRC) survivors are at increased risk of hypertension, high cholesterol, type 2 diabetes, and subsequently cardiovascular disease (CVD). This influences their quality of life and healthcare costs, and contributes to premature death.

However, no interventions exist that are specifically designed to help people with CRC who are at high risk of CVD to improve their physical activity, diet and sleep. The results of this study will help design an intervention to help solve these problems for this population.

Status: Ongoing

Predicting responses to chemotherapy in breast cancer treatment

James Thorne — University of Leeds

Some breast cancer tumours can become resistant to chemotherapy treatment and it is unclear why a particular chemotherapy drug works better for one patient but not for others.

This study will identify chemotherapy pathways altered by nutrients in breast cancer to help develop a new prediction tool that can be used by doctors to select the best treatment for individual patients. This means that they would be able to identify patients who won’t respond to a particular drug.

Status: Ongoing

Health behaviour interventions for Indigenous Australian cancer survivors

Gail Garvey — University of Queensland

Indigenous Australians have poorer cancer outcomes compared with non-Indigenous people. In Queensland, Indigenous health workers trained as Indigenous Patient Navigators (IPN) have been used to reduce cancer disparities through their understanding of cultural and practical issues facing Indigenous patients, addressing barriers, and streamlining care.

This study will find out whether having an IPN deliver a health behaviour intervention is feasible and acceptable to Indigenous cancer survivors.

Status: Ongoing

How much do preventable risk factors increase the burden of cancer?

Robert MacInnis — Cancer Council Victoria

Certain behaviours or risk factors are known to increase the chance of cancer developing. Current policies and campaigns aimed at reducing the number of people who will develop cancer have not used the most recent data on how common these behaviours are, and they have not estimated the future impact on the numbers of new cancers. This study will update the data to increase the relevance of the findings to worldwide cancer prevention activities.

Status: Ongoing